Course of clinical high-risk states for psychosis beyond conversion

European Archives of Psychiatry and Clinical Neuroscience

Volumn 268, Issue 1, 2018, Pages 39-48

  Michel, Chantal ^a   Ruhrmann, Stephan ^b   Schimmelmann, Benno G ^a   Klosterkötter, Joachim ^b   Schultze Lutter, Frauke ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Axis I diagnosis; Clinical high risk; Non conversion; Persistence; Remission

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; REMISSION; RISK ASSESSMENT; ADOLESCENT; INCIDENCE; LONGITUDINAL STUDY; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MOOD DISORDERS; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 85008219884     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-016-0764-8     Document Type: Article

References (47)

1. Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RK, Riecher-Rössler A, van der Gaag M, Nordentoft M, Raballo A, Meneghelli A, Marshall M, Morrison A, Ruhrmann S, Klosterkötter J (2015) EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 30(3):405–416
2. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39(11–12):964–971
3. McGlashan TH, Walsh BC, Woods SW (2010) The Psychosis-risk syndrome: handbook for diagnosis and follow-up. Oxford University Press, New York
4. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A (2013) The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 70(1):107–120
5. Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG, Klosterkötter J (2012) Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des 18(4):351–357
6. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 159(5):863–865
7. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003) Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 60(1):21–32
8. Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, Birchwood M, Patterson P, Juckel G, Heinz A, Morrison A, Lewis S, von Reventlow HG, Klosterkötter J (2010) Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 67(3):241–251
9. Schultze-Lutter F, Klosterkötter J, Ruhrmann S (2014) Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res 154(1–3):100–106
10. Ruhrmann S, Schultze-Lutter F, Klosterkötter J (2010) Sub-threshold states of psychosis – a challenge to diagnosis and treatment. Clin Neuropsychiatr 7(2):72–87
11. Ruhrmann S, Schultze-Lutter F, Schmidt SJ, Kaiser N, Klosterkotter J (2014) Prediction and prevention of psychosis: current progress and future tasks. Eur Arch Psychiatry Clin Neurosci 264(Suppl 1):S9–S16
12. Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkötter J (2010) Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 36(1):182–191
13. Lemos-Giráldez S, Vallina-Fernández O, Fernández-Iglesias P, Vallejo-Seco G, Fonseca-Pedrero E, Paíno-Piñeiro M, Sierra-Baigrie S, García-Pelayo P, Pedrejón-Molino C, Alonso-Bada S, Gutiérrez-Pérez A, Ortega-Ferrández JA (2009) Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res 115(2–3):121–129
14. Velthorst E, Nieman DH, Klaassen RM, Becker HE, Dingemans PM, Linszen DH, De Haan (2011) Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis. Acta Psychiatr Scand 123(1):36–42
15. Velthorst E, Nelson B, Wiltink S, de Haan L, Wood SJ, Lin A, Yung AR (2013) Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key? Schizophr Res 143(1):132–137
16. Carrión RE, McLaughlin D, Goldberg TE, Auther AM, Olsen RH, Olvet DM, Correll CU, Cornblatt BA (2013) Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry 70(11):1133–1142
17. de Wit S, Schothorst PF, Oranje B, Ziermans TB, Durston S, Kahn RS (2014) Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state. Eur Neuropsychopharmacol 24(6):865–873
18. Ziermans T, de Wit S, Schothorst P, Sprong M, van Engeland H, Kahn R, Durston S (2014) Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up. PLoS One 9(4):e93994
19. Simon AE, Borgwardt S, Riecher-Rössler A, Velthorst E, de Haan L, Fusar-Poli P (2013) Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis. Psychiatry Res 209(3):266–272
20. American Psychiatric Association (APA) (1994) Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). American Psychiatric. Press, Washington, DC
21. Hall RC (1995) Global assessment of functioning. A modified scale. Psychosomatics 36(3):267–275
22. McGlashan TH, Miller TJ, Woods SW, Rosen JL, Hoffman RE, Davidson L (2001) Structured interview for prodromal syndromes (version 3.0). Yale School of Medicine, PRIME Research Clinic, New Haven
23. Haroun N, Dunn L, Haroun A, Cadenhead KS (2006) Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 32(1):166–178
24. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R (2011) At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 168(8):800–805
25. Ziermans TB, Schothorst PF, Sprong M, van Engeland H (2011) Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res 126(1–3):58–64
26. Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, Bearden CE, Cannon TD (2012) Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull 38(6):1225–1233
27. Simon AE, Grädel M, Cattapan-Ludewig K, Gruber K, Ballinari P, Roth B, Umbricht D (2012) Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res 142(1–3):108–115
28. Lee TY, Kim SN, Correll CU, Byun MS, Kim E, Jang JH, Kang DH, Yun JY, Kwon JS (2014) Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study. Schizophr Res 156(2–3):266–271
29. Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH (2014) Current status specifiers for patients at clinical high risk for psychosis. Schizophr Res 158(1–3):69–75
30. Eslami A, Jahshan C, Cadenhead KS (2011) Disorganized symptoms and executive functioning predict impaired social functioning in subjects at risk for psychosis. J Neuropsychiatr Clin Neurosci 23(4):457–460
31. Correll CU, Smith CW, Auther AM, McLaughlin D, Shah M, Foley C, Olsen R, Lencz T, Kane JM, Cornblatt BA (2008) Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. J Child Adolesc Psychopharmacol 18(5):475–490
32. Armando M, Pontillo M, De Crescenzo F, Mazzone L, Monducci E, Lo Cascio N, Santonastaso O, Pucciarini ML, Vicari S, Schimmelmann BG, Schultze-Lutter F (2015) Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents. Schizophr Res 169(1–3):186–192
33. Schultze-Lutter F, Ruhrmann S, Klosterkötter J (2009) Early detection of psychosis—establishing a service for persons at risk. Eur Psychiatry 24(1):1–10
34. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ (1998) Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 172(33):14–20
35. Gross G, Huber G, Klosterkötter J, Linz M (1987) Bonner Skala für die Beurteilung von Basissymptomen [BSABS; Bonn Scale for the Assessment of Basic Symptoms]. Springer, Berlin
36. Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J (2007) Schizophrenia proneness instrument, adult version (SPI-A). Giovanni Fioriti Editore s.l.r., Rome
37. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, Hoffman RE, Davidson L (1999) Symptom assessment in schizophrenic prodromal states. Psychiatr Q 70(4):273–287
38. Michel C, Schimmelmann BG, Kupferschmid S, Siegwart M, Schultze-Lutter F (2014) Reliability of telephone assessments of at-risk criteria of psychosis: a comparison to face-to-face interviews. Schizophr Res 153(1–3):251–253
39. Wittchen HU, Zaudig M, Fydrich T (1997) SKID - Strukturiertes klinisches Interview für DSM-IV, Achse I und II. Hogrefe, Göttingen
40. Schultze-Lutter F, Schimmelmann BG, Klosterkötter J, Ruhrmann S (2012) Comparing the prodrome of schizophrenia-spectrum psychoses and affective disorders with and without psychotic features. Schizophr Res 138(2–3):218–222
41. Lin A, Wood SJ, Nelson B, Beavan A, McGorry P, Yung AR (2015) Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry 172(3):249–258
42. Schultze-Lutter F (2009) Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull 35(1):5–8
43. Salokangas RKR, Ruhrmann S, von Reventlow HG, Heinimaa M, Svirskis T, From T, Luutonen S, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Schultze-Lutter F, Klosterkötter J (2012) Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr Res 138(2–3):192–197
44. Hui C, Morcillo C, Russo DA, Stochl J, Shelley GF, Painter M, Jones PB, Perez J (2013) Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis. Schizophr Res 148(1–3):175–180
45. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK (2014) Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 40(1):120–131
46. Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG (2014) Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern epidemiological at-risk (BEAR) study. Schizophr Bull 40(6):1499–1508
47. Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewer WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR (2013) Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA. Psychiatry 70(8):793–802